Tong J, Li D, Meng H, Sun D, Lan X, Ni M
Read article Learn how online assessment, provider review, medication options, eligibility, costs, insurance, and follow-up work
Semaglutide trials demonstrated average body weight reductions of around 15% over 68 weeks in adults with obesity
However, studies on GLP-1 agonists in pregnant animals showcased pregnancy risks, low birth weight, and skeletal deformities
In future, once data are available on a larger number of patients switching treatments, the use of administrative claims data in similar analyses would help to increase confidence that the patients represented are those who have collected and adhered to treatment following switching